These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37757825)
21. Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models. Ting KK; Zhao Y; Shen W; Coleman P; Yam M; Chan-Ling T; Li J; Moller T; Gillies M; Vadas MA; Gamble JR Diabetologia; 2019 Feb; 62(2):322-334. PubMed ID: 30443753 [TBL] [Abstract][Full Text] [Related]
22. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor. Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809 [TBL] [Abstract][Full Text] [Related]
23. Scutellarin alleviates blood-retina-barrier oxidative stress injury initiated by activated microglia cells during the development of diabetic retinopathy. Mei X; Zhang T; Ouyang H; Lu B; Wang Z; Ji L Biochem Pharmacol; 2019 Jan; 159():82-95. PubMed ID: 30447218 [TBL] [Abstract][Full Text] [Related]
24. Tofacitinib Ameliorates Retinal Vascular Leakage in a Murine Model of Diabetic Retinopathy with Type 2 Diabetes. Byrne EM; Llorián-Salvador M; Lyons TJ; Chen M; Xu H Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769307 [TBL] [Abstract][Full Text] [Related]
25. Transcriptomics analysis of pericytes from retinas of diabetic animals reveals novel genes and molecular pathways relevant to blood-retinal barrier alterations in diabetic retinopathy. Rangasamy S; Monickaraj F; Legendre C; Cabrera AP; Llaci L; Bilagody C; McGuire P; Das A Exp Eye Res; 2020 Jun; 195():108043. PubMed ID: 32376470 [TBL] [Abstract][Full Text] [Related]
26. Thymoquinone Attenuates Retinal Expression of Mediators and Markers of Neurodegeneration in a Diabetic Animal Model. Alkharfy KM; Ahmad A; Siddiquei MM; Ghulam M; El-Asrar AA Curr Mol Pharmacol; 2023; 16(2):188-196. PubMed ID: 35049444 [TBL] [Abstract][Full Text] [Related]
27. OMICs approaches-assisted identification of macrophages-derived MIP-1γ as the therapeutic target of botanical products TNTL in diabetic retinopathy. Wang N; Zhang C; Xu Y; Li S; Tan HY; Xia W; Feng Y Cell Commun Signal; 2019 Jul; 17(1):81. PubMed ID: 31331327 [TBL] [Abstract][Full Text] [Related]
28. Protective Effect of Palm Oil-Derived Tocotrienol-Rich Fraction Against Retinal Neurodegenerative Changes in Rats with Streptozotocin-Induced Diabetic Retinopathy. Sadikan MZ; Nasir NAA; Agarwal R; Ismail NM Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32260544 [No Abstract] [Full Text] [Related]
29. Lignans Extracted from Eucommia Ulmoides Oliv. Protects Against AGEs-Induced Retinal Endothelial Cell Injury. Liu B; Li CP; Wang WQ; Song SG; Liu XM Cell Physiol Biochem; 2016; 39(5):2044-2054. PubMed ID: 27825165 [TBL] [Abstract][Full Text] [Related]
30. The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice. Hanaguri J; Yokota H; Kushiyama A; Kushiyama S; Watanabe M; Yamagami S; Nagaoka T Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163285 [TBL] [Abstract][Full Text] [Related]
31. Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress-mediated Wnt/β-catenin pathway activation. Liu Q; Zhang X; Cheng R; Ma JX; Yi J; Li J Cell Tissue Res; 2019 May; 376(2):165-177. PubMed ID: 30610453 [TBL] [Abstract][Full Text] [Related]
33. Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells Zhang T; Ouyang H; Mei X; Lu B; Yu Z; Chen K; Wang Z; Ji L FASEB J; 2019 Nov; 33(11):11776-11790. PubMed ID: 31365278 [TBL] [Abstract][Full Text] [Related]
34. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R. Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864 [TBL] [Abstract][Full Text] [Related]
35. Tocotrienol-rich fraction supplementation reduces hyperglycemia-induced skeletal muscle damage through regulation of insulin signaling and oxidative stress in type 2 diabetic mice. Lee H; Lim Y J Nutr Biochem; 2018 Jul; 57():77-85. PubMed ID: 29679925 [TBL] [Abstract][Full Text] [Related]
36. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats. Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990 [TBL] [Abstract][Full Text] [Related]
38. A prodrug of epigallocatechin-3-gallate alleviates high glucose-induced pro-angiogenic factor production by inhibiting the ROS/TXNIP/NLRP3 inflammasome axis in retinal Müller cells. Du J; Wang Y; Tu Y; Guo Y; Sun X; Xu X; Liu X; Wang L; Qin X; Zhu M; Song E Exp Eye Res; 2020 Jul; 196():108065. PubMed ID: 32407725 [TBL] [Abstract][Full Text] [Related]
39. Diabetic eNOS-knockout mice develop accelerated retinopathy. Li Q; Verma A; Han PY; Nakagawa T; Johnson RJ; Grant MB; Campbell-Thompson M; Jarajapu YP; Lei B; Hauswirth WW Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5240-6. PubMed ID: 20435587 [TBL] [Abstract][Full Text] [Related]
40. Antioxidant and anti-apoptotic effects of tocotrienol-rich fraction against streptozotocin-induced diabetic retinopathy in rats. Sadikan MZ; Nasir NAA; Iezhitsa I; Agarwal R Biomed Pharmacother; 2022 Sep; 153():113533. PubMed ID: 36076612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]